NDC 70771-1529-01 - doxepin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70771-1529
- Requested NDC
- 70771-1529-01
- Package NDCs from labels
- 70771-1529-3, 70771-1529-9, 70771-1529-1, 70771-1529-5, 70771-1529-0, 70771-1529-4, 70771-1529-01
- Manufacturer
- Zydus Lifesciences Limited
- Effective date
- 2025-01-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| doxepin - Zydus Lifesciences Limited | Zydus Lifesciences Limited | 2025-01-08 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70771-1529-0 | doxepin | 1000 in 1 BOTTLE | TABLET | 1000 | 3 | |
| 70771-1529-1 | doxepin | 100 in 1 BOTTLE | TABLET | 100 | 3 | |
| 70771-1529-3 | doxepin | 30 in 1 BOTTLE | TABLET | 30 | 3 | |
| 70771-1529-4 | doxepin | 10 in 1 CARTON | TABLET | 10 | 3 | |
| 70771-1529-4 | doxepin | 10 in 1 BLISTER PACK | TABLET | 10 | 3 | |
| 70771-1529-5 | doxepin | 500 in 1 BOTTLE | TABLET | 500 | 3 | |
| 70771-1529-9 | doxepin | 90 in 1 BOTTLE | TABLET | 90 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70771-1529 | DOXEPIN TABLET [ZYDUS LIFESCIENCES LIMITED] | 3 | Current NDC, 7 package rows | 20250110_1461ede6-24f0-42a1-b801-0cf4ef404985.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxepin | DOXEPIN | Actavis Pharma, Inc. | c42333f8-1add-4f33-9458-6fe4436874a1 | 2023-06-01 | Warnings, Adverse reactions | 966793 966787 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | 14002bad-2577-436d-91ca-ec1b80ab0c97 | 2023-03-17 | Boxed warning, Warnings, Adverse reactions | 3U9A0FE9N5 |
| DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | Alembic Pharmaceuticals Limited | 842b595b-dc54-4898-a178-1d2241cc065f | 2023-01-27 | Boxed warning, Warnings, Adverse reactions | 3U9A0FE9N5 |
| Doxepin hydrochloride | DOXEPIN HYDROCHLORIDE | Proficient Rx LP | acb696a8-a74c-4c5d-9ce3-88f67558c2f2 | 2022-09-01 | Boxed warning, Warnings, Adverse reactions | 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Proficient Rx LP | 6ce7fde2-2d47-4238-9beb-555d352f4657 | 2022-05-02 | Boxed warning, Warnings, Adverse reactions | 3U9A0FE9N5 |
| doxepin hydrochloride | DOXEPIN HYDROCHLORIDE | Currax Pharmaceuticals LLC dba Cypress, Hawthorn, Macoven | 5b4dba99-6b66-4091-94f1-bf5f021c688a | 2022-01-20 | Warnings, Adverse reactions | 966793 966787 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Florida Pharmaceutical Products, LLC | b787a283-f882-e1f0-e053-2a95a90a8975 | 2021-09-24 | Boxed warning, Warnings, Adverse reactions | 3U9A0FE9N5 |
| doxepin hydrochloride | DOXEPIN HYDROCHLORIDE | Teva Pharmaceuticals USA, Inc. | 4a4eab1c-8e19-48f5-9216-09ab83eaa5f8 | 2021-06-01 | Warnings, Adverse reactions | 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Appco Pharma LLC | abf4c515-8888-4733-80a0-fd4e1cdb84a2 | 2021-04-29 | Boxed warning, Warnings, Adverse reactions | 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Proficient Rx LP | e98f371e-f7fe-4c8f-9491-6eb4c53d43ad | 2021-02-01 | Boxed warning, Warnings, Adverse reactions | 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Contract Pharmacal Corp. | abbf7078-a012-4e1a-e053-2995a90a792d | 2020-08-06 | Boxed warning, Warnings, Adverse reactions | 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 10d9eba6-30d1-448a-8d92-a1a02df03303 | 2017-09-05 | Boxed warning, Warnings, Adverse reactions | 3U9A0FE9N5 |
| PRUDOXIN | DOXEPIN HYDROCHLORIDE | Mylan Pharmaceuticals Inc. | ca53346b-8ab3-4722-98f6-cf272706d3fa | 2017-06-29 | Warnings, Adverse reactions | 3U9A0FE9N5 |
| Zonalon | DOXEPIN HYDROCHLORIDE | Mylan Pharmaceuticals Inc. | 5f302247-525e-4acc-852b-00eb1d79af4b | 2017-06-14 | Warnings, Adverse reactions | 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Mylan Pharmaceuticals Inc. | b4771ea7-c19b-4182-bb23-c1473ab583fa | 2017-05-24 | Warnings, Adverse reactions | 3U9A0FE9N5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.